# Myra Ahmad (Founder & CEO of Mochi Health) - The future of GLP-1s

Page: https://stenobird.com/podcast/hims-house-7026583/myra-ahmad-founder-ceo-of-mochi-health-the-future-of-glp-1s
Text version: https://stenobird.com/podcast/hims-house-7026583/myra-ahmad-founder-ceo-of-mochi-health-the-future-of-glp-1s.md
Podcast: [Hims House](https://stenobird.com/podcast/hims-house-7026583)
Published: 2026-02-12T13:00:00+00:00
Episode link: https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Myra-Ahmad-Founder--CEO-of-Mochi-Health---The-future-of-GLP-1s-e3evv8a
Audio file: https://anchor.fm/s/10e9c0874/podcast/play/115391178/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-1-12%2F417953106-44100-2-501168a2124b7.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/myra-ahmad-founder-ceo-of-mochi-health-the-future-of-glp-1s
Duration seconds: 2652

## Resource

In Episode 56 of Hims House, Jonathan Stern sits down with Myra Ahmad, founder and CEO of Mochi Health, to unpack where GLP-1s are headed - and how Mochi is building a broader telehealth marketplace around metabolic care. Myra explains Mochi’s pharmacy “marketplace” model and how she thinks about staying compliant with compounded GLP-1 pills amid increasing FDA scrutiny. They discuss oral vs. injectable GLP-1s, why pills may be an on-ramp but not a long-term winner for most patients, and what the Hims GLP-1 pill episode signals about enforcement and risk. Myra also outlines Mochi’s expansion beyond weight loss, including longevity and labs, and where AI can (and can’t) meaningfully replace humans in healthcare. The conversation closes with predictions on the next wave of GLP-1s. 00:00 - Sponsor: Mochi Health 01:56 - Mochi's compounded semaglutide pill 04:27 - Oral vs. injectable GLP-1s 11:25 - $HIMS GLP-1 pill blowback 17:19 - FDA enforcement risk and what could change 22:27 - Patents, “personalization,” and where compounders may get exposed 24:05 - Mochi's growth story 24:47 - Retatrutide 31:32 - Why the U.S. could resemble Canada's system 34:09 - AI in healthcare 37:40 - Labs, GRAIL, and prevention 41:01 - The next era of GLP-1s Disclaimer: This podcast is for informational and entertainment purposes only. Nothing discussed should be considered financial, investment, or legal advice. Always consult with a qualified professional before making financial decisions.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/myra-ahmad-founder-ceo-of-mochi-health-the-future-of-glp-1s/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/hims-house-7026583/myra-ahmad-founder-ceo-of-mochi-health-the-future-of-glp-1s.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.